Regent Pacific Group Ltd (fra:RPG) Share Price

Company Profile

Business description
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
Contact
5 Queen's Road Central
8th Floor, Henley Building
Hong Kong
HKG
T: +852 25146111
https://www.endurancerp.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
16

Recommended

Short term headwinds mask long term value opportunity.

Brian Han | 25 August 2026

Geopolitical tensions drive strong profit and dividends for oil refiner.

Mark Taylor | 25 August 2026

Higher costs weigh on profits but stronger sales trends support long term outlook.

Johannes Faul, CFA | 25 August 2026

Index	Last price	Change	% Change
All Ordinaries	9,388.60	4.70	-0.05%
CAC 40	8,439.20	13.81	-0.16%
DAX 40	26,266.14	159.54	0.61%
Dow JONES (US)	53,577.40	160.24	0.30%
FTSE 100	10,886.16	31.84	0.29%
HKSE	25,511.10	6.23	-0.02%
NASDAQ	26,151.30	171.11	0.66%
Nikkei 225	65,580.17	276.26	-0.42%
NZX 50 Index	14,005.47	12.75	0.09%
S&P 500	7,677.28	24.42	0.32%
S&P/ASX 200	9,179.10	4.60	-0.05%
SSE Composite Index	3,889.44	7.44	0.19%